Biocytogen Pharmaceuticals (Beijing) Co Ltd - Class H

NEW
FRA:I54 (China)   Class H
€ 7.4 +0.65 (+9.63%) Aug 10
142.28
P/B:
12.42
Market Cap:
€ 6.72B ($ 7.76B)
Enterprise V:
€ 6.65B ($ 7.68B)
Volume:
0
Avg Vol (2M):
99.00
Trade In:

Biocytogen Pharmaceuticals (Beijing) Co Ltd (FRA:I54) Dividend

Biocytogen Pharmaceuticals (Beijing) Co Ltd (FRA:I54) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -3.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:I54 Dividend

Does Biocytogen Pharmaceuticals (Beijing) Co Ltd (FRA:I54) pay a dividend?

Biocytogen Pharmaceuticals (Beijing) Co Ltd (FRA:I54) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Biocytogen Pharmaceuticals (Beijing) Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Biocytogen Pharmaceuticals (Beijing) Co Ltd has returned capital to shareholders via buybacks at a rate of -3.6% over the past 3 years.

What are dividend-paying alternatives to Biocytogen Pharmaceuticals (Beijing) Co Ltd?

For dividend-paying alternatives in Biocytogen Pharmaceuticals (Beijing) Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.